Pallas Health vs Gala: clinician choice vs flat-price compounded care
Pallas Health vs Gala quickly compared: Pallas emphasizes clinician choice between FDA-approved brand-name GLP-1s and per-patient compounded options, while Gala emphasizes a single flat-price compounded plan and a $220 promotion. Early verdict: choose Pallas if you want a clinician to pick brand or compounded treatment; choose Gala if you prefer a flat all-in compounded price and a limited promotion.
See Pallas Health plans and clinician options
Pallas Health vs Gala: how they differ at a glance
This comparison focuses on the most distinctive differences supported by the sources: medication options and clinician selection, pricing structure and first-month pricing, shipping and delivery promises, transparency of base price and promotions, and membership or renewal terms. Both offer compounded semaglutide and tirzepatide and both note that compounded medications are not FDA approved.
1. Medication options and clinician role
Pallas Health: a US licensed clinician reviews your history and personalizes the plan, offering FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro or compounded semaglutide and tirzepatide when a brand medication is not the right fit. Gala: offers compounded semaglutide and tirzepatide with provider visit and prescription included. The key contrast is that Pallas explicitly positions a clinician to choose between brand-name pens and per-patient compounded preparations, while Gala presents direct-pay compounded care with a provider visit included.
Check Gala eligibility and promotional price
2. Pricing structure and first-month pricing
Pallas publishes a clear compounded intro price: compounded semaglutide $139 first month then $597 every 12 weeks, a $199/month average; compounded tirzepatide $179 first month then $897 every 12 weeks, a $299/month average. Pallas also lists cash-pay brand prices such as Wegovy at $1,349/month cash pay. Gala advertises a flat all-inclusive price at every dose and a $220 discount promotion, but the landing page did not expose a base monthly dollar price in readable text. The exact published first-month figures are supplied for Pallas but not for Gala.
View Pallas pricing and plan details
3. Shipping, delivery and renewal cadence
Pallas promises free expedited discreet shipping and notes compounded plans renew every 12 weeks rather than monthly, so cancellation timing matters. Gala advertises free two-day shipping straight to your door and promotes cancel anytime and no monthly membership. Both mention that treatment is available only when a licensed clinician determines it is medically appropriate, and both include provider care and check-ins in plan pricing as described by each source.
4. Transparency, enrollment and memberships
Pallas is cash-pay only and does not bill insurance; the source notes FSA/HSA use needs a Letter of Medical Necessity. Pallas says it does not manufacture or compound medication and that compounding is done by US-licensed compounding pharmacies. Gala states no insurance is needed, no monthly membership and cancel anytime, and it claims the same price at every dose. The sources differ in how clearly the base recurring price is shown: Pallas supplies specific renewal math for compounded plans; Gala does not show a base dollar price in the readable text captured.
Comparison table: Pallas Health vs Gala
| Criteria | Pallas Health | Gala |
|---|---|---|
| Medication options | FDA-approved brand-name GLP-1s and compounded semaglutide or tirzepatide | Compounded semaglutide and tirzepatide |
| Clinician role | US-licensed clinician personalizes plan and may choose brand or compounded | Provider visit and prescription included for compounded care |
| Starting price | Compounded semaglutide $139 first month then $199/mo avg | $220 promotion advertised; base price not visible in captured text |
| Shipping | Free expedited discreet shipping | Free two-day shipping |
| Memberships and billing | No membership fee; cash-pay only; plans renew every 12 weeks for compounded | No monthly membership; cancel anytime; one flat price claimed |
Regulatory and safety notes
Both sources clearly state that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. Pallas explicitly notes compounding is performed by US licensed compounding pharmacies and that the medication received may differ in appearance from site images. Gala also includes the regulatory note that compounded medications are not FDA approved.
Which should you choose?
Choose Pallas Health if you want a clinician to choose between brand-name GLP-1 pens and a personalized compounded preparation, and if you value published introductory compound pricing such as compounded semaglutide $139 first month then $597 every 12 weeks ($199/mo avg) and free expedited discreet shipping.
Explore Gala compounded plan and promotion
Start Pallas intake to see clinician options
Choose Gala if you prefer a flat all-in compounded price with a $220 promotion and free two-day shipping and want the provider visit and prescription included under a single direct-pay plan. Confirm state availability, renewal terms and the exact base price with Gala before enrollment because the captured page did not expose a readable base monthly dollar amount.
In summary, Pallas Health vs Gala is a clinician-centered brand-or-compound approach versus a flat-price compounded approach with a promotion. Use the details above to align your choice with whether clinician selection of brand medications matters more to you or whether a single flat compounded price and an advertised promotion are the priority.